(Q61955435)
Statements
Effect of Bortezomib (Velcade)-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro (English)
0 references
October 2010
0 references
January 2018
0 references
11
0 references
18 year
0 references